Sirolimus and tacrolimus coefficient of variation is associated with rejection, donor-specific antibodies, and nonadherence

Pediatric Nephrology

Volumn 31, Issue 12, 2016, Pages 2345-2352

  Pizzo, Helen P ^a   Ettenger, Robert B ^b   Gjertson, David W ^c   Reed, Elaine F ^c   Zhang, Jennifer ^c   Gritsch, H Albin ^c   Tsai, Eileen W ^b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b MATTEL CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Calcineurin inhibitor; Compliance; Drug levels; Immunosuppression; Mammalian target of rapamycin inhibitor

Indexed keywords

ANTIBODY; RAPAMYCIN; TACROLIMUS; IMMUNOSUPPRESSIVE AGENT;

ACUTE GRAFT REJECTION; ADOLESCENT; ANTIBODY MEDIATED REJECTION; ANTIBODY SPECIFICITY; ARTICLE; CHILD; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; GLOMERULOPATHY; HLA TYPING; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; KIDNEY DONOR; MALE; MEDICATION COMPLIANCE; PATIENT-REPORTED OUTCOME; PILOT STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT REFUSAL; DONOR; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOLOGY; INFANT; KIDNEY; KIDNEY TRANSPLANTATION; PATHOLOGY; PRESCHOOL CHILD; PROCEDURES; TREATMENT OUTCOME;

ANTIBODIES; CHILD; CHILD, PRESCHOOL; FEASIBILITY STUDIES; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MEDICATION ADHERENCE; PILOT PROJECTS; RETROSPECTIVE STUDIES; SIROLIMUS; TACROLIMUS; TISSUE DONORS; TREATMENT OUTCOME;

EID: 84973667578     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-016-3422-5     Document Type: Article

References (30)

1. Dobbels F, Ruppar T, De Geest S, Decorte A, Van Damme-Lombaerts R, Fine RN (2010) Adherence to the immunosuppressive regimen in pediatric kidney transplant recipients: a systematic review. Pediatr Transplant 14:603–613
2. Sellares J, de Freitas D, Mengel M, Reeve J, Einecke G, Sis B, Hidalgo LG, Famulski K, Matas A, Halloran PF (2012) Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am J Transplant 12:388–399
3. Wiebe C, Gibson I, Blydt-Hansen T, Karpinski M, Ho J, Storsley LJ, Goldberg A, Birk PE, Rush DN, Nickerson PW (2012) Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant. Am J Transplant 12:1157–1167
4. Marcen R, Teruel J (2008) Patient outcomes after kidney allograft loss. Transplant Rev 22:62–72
5. Pinsky BW, Takemoto SK, Lentine KL, Burroughs TE, Schnitzler MA, Salvalaggio PR (2009) Transplant outcomes and economic costs associated with patient noncompliance to immunosuppression. Am J Transplant 9:2597–2606
6. Tsai EW, Wallace WD, Gjertson DW, Reed EF, Ettenger RB (2010) Significance of intragraft CD138+ lymphocytes and p-S6RP in pediatric kidney transplant biopsies. Transplantation 90:875–881
7. Schafer-Keller P, Steiger J, Bock A, Denhaerynck K, De Geest S (2008) Diagnostic accuracy of measurement methods to assess non-adherence to immunosuppressive drugs in kidney transplant recipients. Am J Transplant 8(3):616–626
8. Osterberg L, Blaschke T (2005) Adherence to medication. N Engl J Med 353:487–497
9. Farmer K (1999) Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther 21:1074–1090
10. Dobbels F, Berben L, De Geest S, Drent G, Lennerling A, Whittaker C, Kugler C, Transplant 360 Task Force (2010) The psychometric properties and practicability of self-report instruments to identify medication nonadherence in adult transplant patients: a systematic review. Transplantation 90(2):205–219
11. Eisenberger U, Wuthrich R, Bock A, Ambuhl P, Steiger J, Intondi A, Kuranoff S, Maier T, Green D, DiCarlo L, Feutren G, De Geest S (2013) Medication adherence assessment: high accuracy of the new Ingestible Sensor System in kidney transplants. Transplantation 96:245–250
12. Shemesh E, Fine R (2010) Is calculating the standard deviation of tacrolimus blood levels the new gold standard for evaluating non-adherence to medications in transplant recipients? Pediatr Transplant 14:940–943
13. Hsiau M, Fernandez H, Gjertson D, Ettenger RB, Tsai EW (2011) Monitoring nonadherence and acute rejection with variation in blood immunosuppressant levels in pediatric renal transplantation. Transplantation 92:918–922
14. Pollock-Barziv SM, Finkelstein Y, Manlhiot C, Dipchand AL, Hebert D, Ng VL, Solomon M, McCrindle BW, Grant D (2010) Variability in tacrolimus blood levels increases the risk of late rejection and graft loss after solid organ transplantation in older children. Pediatr Transplant 14:968–975
15. Staatz CE, Tett SE (2007) Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients. Clin Pharmacokinet 46:13–58
16. Garcia CD, Bittencourt VB, Alves AB, Garcia VD, Tumelero A, Antonello JS, Malheiros D (2006) Conversion to sirolimus in pediatric renal transplantation recipients. Transplant Proc 38(6):1901–1903
17. MacDonald AS (2003) Rapamycin in combination with cyclosporine or tacrolimus in liver, pancreas, and kidney transplantation. Transplant Proc 35:201S–208S
18. Schachter AD, Benfield MR, Wyatt RJ, Grimm PC, Fennell RS, Herrin JT, Lirenman DS, McDonald RA, Munoz-Arizpe R, Harmon WE (2006) Sirolimus pharmacokinetics in pediatric renal transplant recipients receiving calcineurin inhibitor co-therapy. Pediatr Transplant 10(8):914–919
19. El-Sabrout R, Delaney V, Qadir M, Butt F, Hanson P, Butt KM (2003) Sirolimus in combination with tacrolimus or mycophenolate mofetil for minimizing acute rejection risk in renal transplant recipients—a single center experience. Transplant Proc 35(3 Suppl):89S–94S.
20. Schubert M, Venkataramanan R, Holt D, Shaw LM, McGhee W, Reyes J, Webber S, Sindhi R (2004) Pharmacokinetics of sirolimus and tacrolimus in pediatric transplant patients. Am J Transplant 4:767–773
21. Butler J, Peveler R, Roderick P, Horne R, Mason J (2004) Measuring compliance with drug regimens after renal transplantation: comparison of self-report and clinician rating with electronic monitoring. Transplantation 15:786–789
22. Bruce JM, Hancock LM, Lynch SG (2010) Objective adherence monitoring in multiple sclerosis: initial validation and association with self-report. Mult Scler 16:112–120
23. Blumberg J, Gritsch H, Reed E, Cecka J, Lipshutz G, Danovitch G, McGuire S, Gjertson DW, Veale JL (2013) Kidney paired donation in the presence of donor-specific antibodies. Kidney Int 84:1009–1016
24. Haas M, Sis B, Racusen LC, Solez K, Glotz D, Colvin RB, Castro MC, David DS, David-Neto E, Bagnasco SM, Cendales LC, Cornell LD, Demetris AH, Drachenberg CB, Farver CF, Farris AB 3rd, Gibson IW, Kraus E, Liapis H, Loupy A, Nickeleit V, Randhawa P, Rodriguez ER, Smith RN, Tan CD, Wallace WD, Mengel M, Banff meeting report writing committee (2014) Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant 14:272–283
25. Pape L, Ahlenstiel T (2014) mTOR inhibitors in pediatric kidney transplantation. Pediatr Nephrol 29(7):1119–1129
26. Ganschow R, Pape L, Sturm E, Bauer J, Melter M, Gerner P, Hocker B, Ahlenstiel T, Kemper M, Brinkert F, Sachse MM, Tonshoff B (2013) Growing experience with mTOR inhibitors in pediatric solid organ transplantation. Pediatr Transplant 17(7):694–706
27. Wu MJ, Shu KH, Lian JD, Yang CR, Cheng CH, Chen CH (2008) Impact of variability of sirolimus trough level on chronic allograft nephropathy. Transplant Proc 40:2202–2205
28. Wiebe C, Pochino D, Blydt-Hansen TD, Ho J, Birk PE, Karpinski M, Goldberg A, Storsley LJ, Gibson IW, Rush DN, Nickerson PW (2013) Class II epitope matching—a strategy to minimize de novo donor-specific antibody development and improve outcomes. Am J Transplant 13:3114–3122
29. Dunn TB, Browne BJ, Gillingham KJ, Kandaswamy R, Humar A, Payne WD, Sutherland DE, Matas AJ (2009) Selective retransplant after graft loss to nonadherence: success with a second chance. Am J Transplant 9:1337–1346
30. Pai ALH, Rausch J, Tackett A, Marsolo K, Drotar D, Goebel J (2012) System for integrated adherence monitoring: real-time non-adherence risk assessment in pediatric kidney transplantation. Pediatr Transplant 16:329–334